检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]北京中医药大学东直门医院肿瘤血液科,100700 [2]教育部,北京市重点实验室,中医内科学100700
出 处:《现代生物医学进展》2008年第9期1637-1639,F0002,共4页Progress in Modern Biomedicine
摘 要:目的:观察新加良附方对移植性小鼠肝癌(H22)生长抑制作用及其对肿瘤组织中Bcl-2和Bax表达影响。方法:建立移植型H22动物模型,并将动物模型随机分模型对照、环磷酰胺(CTX)与新加良附方大、中、小剂量5组。新加良附大、中、小剂量组给药量分别为10g/kg、5g/kg和2.5g/kg;CTX组给药计量为17mg/kg;模型组给予等量无菌生理盐水。连续给药、给水12天处死模型小鼠分离肿瘤,检测肿瘤大小、称重计算肿瘤抑制率,并将肿瘤组织切片,免疫组化法检测Bcl-2和Bax基因。结果:新加良附大剂量组肿瘤抑制率为48.5%,与模型对照组比较,有统计学意义(P<0.01);新加良附大、中剂量可降低肿瘤组织中Bcl-2蛋白基因表达,升高Bax蛋白基因表达,与模型组比较,有显著性差异(P<0.01,P<0.05)。结论:新加良附方可抑制H22瘤体生长,且下调Bcl-2蛋白基因表达,上调Bax基因,提示新加良附方在抗肿瘤方面具有进一步深入研究价值。Objective: To observe the effect of Xinjia Liangfu recipe on tumor growth of transplanted hepato-carcinaoma in mice and expressions of Bcl-2 and Bax proteins in tumor tissues. Methods 50 healthy Kunming mice,, transplanted by H22 hepatocarcinoma cells, were divided imo 5 groups, including model group, cyclophosphamide group and three groups ofXinjia Liangfu recipe in high dose (10g/kg), medium dose(5g/kg) and low dose(2.5g/kg). The dose of cyclophosphamide group was 17mg/kg, the model group were treated with the same volume germfree saline. The mice were killed after twelve days of the drugs and water treatment and tumor tissues were separated. The size and weight of tumor tissues were measured and the tumor inhibition rate was calculated. And expressions of Bcl-2 and Bax were detected by using immunohistochemical method. Result: The tumor inhibition rate of Xinjia Liangfu recipe group in high dose was 48.5% and was higher obviously than that in model group (P〈0.01 ). Compared to the model group, expression of Bcl-2 protein increased and the expression of Bax protein decreased in the groups of Xinjia Liangfu recipe in high dose and medium dose (P〈0.01, P〈0.05 ). Conclusion: Xinjia Liangfu recipe could inhibit the growth of tumor of H22, reduce the expression of Bcl-2 protein and raise the expression of Bax,which is worth further studying in antitumor.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.233